Cargando…
Epigenetic therapy of novel tumour suppressor ZAR1 and its cancer biomarker function
BACKGROUND: Cancer still is one of the leading causes of death and its death toll is predicted to rise further. We identified earlier the potential tumour suppressor zygote arrest 1 (ZAR1) to play a role in lung carcinogenesis through its epigenetic inactivation. RESULTS: We are the first to report...
Autores principales: | Deutschmeyer, Verena, Breuer, Janina, Walesch, Sara K., Sokol, Anna M., Graumann, Johannes, Bartkuhn, Marek, Boettger, Thomas, Rossbach, Oliver, Richter, Antje M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6894338/ https://www.ncbi.nlm.nih.gov/pubmed/31801617 http://dx.doi.org/10.1186/s13148-019-0774-2 |
Ejemplares similares
-
ZAR1 is a novel epigenetically inactivated tumour suppressor in lung cancer
por: Richter, Antje M., et al.
Publicado: (2017) -
Aberrant Promoter Methylation of the Tumour Suppressor RASSF10 and Its Growth Inhibitory Function in Breast Cancer
por: Richter, Antje M., et al.
Publicado: (2016) -
Muerte al zar/
por: Williams, Andrew 1970-
Publicado: (2011) -
El loco del zar /
por: Kross, Jaan
Publicado: (1992) -
Epigenetically silenced apoptosis-associated tyrosine kinase (AATK) facilitates a decreased expression of Cyclin D1 and WEE1, phosphorylates TP53 and reduces cell proliferation in a kinase-dependent manner
por: Woods, Michelle L., et al.
Publicado: (2022)